{"product_id":"mots-c-40mg-vial","title":"MOTS-c 40mg vial","description":"\u003cp class=\"\" data-end=\"917\" data-start=\"471\"\u003e\u003cstrong data-end=\"481\" data-start=\"471\"\u003e\u003cstrong data-start=\"377\" data-end=\"392\"\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cstrong\u003e                                             \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003e\u003cstrong\u003eFOR HUMAN CONSUMPTION\u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"\" data-end=\"917\" data-start=\"471\"\u003e\u003cstrong data-end=\"481\" data-start=\"471\"\u003eMOTS-c\u003c\/strong\u003e is a recently discovered mitochondrial-derived peptide encoded by mitochondrial DNA. Identified in 2015, MOTS-c plays a significant role in regulating metabolism, energy homeostasis, mitochondrial function, insulin sensitivity, and potentially longevity. Due to its unique mitochondrial origin and metabolic-regulatory properties, MOTS-c has attracted interest as a potential therapeutic agent in metabolic and aging-related disorders.\u003c\/p\u003e\n\u003chr class=\"\" data-end=\"922\" data-start=\"919\"\u003e\n\u003ch2 class=\"\" data-end=\"961\" data-start=\"924\"\u003eChemical and Biological Properties\u003c\/h2\u003e\n\u003cul data-end=\"1382\" data-start=\"963\"\u003e\n\u003cli class=\"\" data-end=\"1040\" data-start=\"963\"\u003e\n\u003cp class=\"\" data-end=\"1040\" data-start=\"965\"\u003e\u003cstrong data-end=\"979\" data-start=\"965\"\u003eFull Name:\u003c\/strong\u003e Mitochondrial Open Reading Frame of the Twelve S rRNA type-c\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"1106\" data-start=\"1041\"\u003e\n\u003cp class=\"\" data-end=\"1106\" data-start=\"1043\"\u003e\u003cstrong data-end=\"1057\" data-start=\"1043\"\u003eStructure:\u003c\/strong\u003e Small peptide (16 amino acids: MRWQEMGYIFYPRKLR)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"1219\" data-start=\"1107\"\u003e\n\u003cp class=\"\" data-end=\"1219\" data-start=\"1109\"\u003e\u003cstrong data-end=\"1120\" data-start=\"1109\"\u003eOrigin:\u003c\/strong\u003e Encoded by mitochondrial DNA, synthesized and released into the cytoplasm and systemic circulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"1382\" data-start=\"1220\"\u003e\n\u003cp class=\"\" data-end=\"1382\" data-start=\"1222\"\u003e\u003cstrong data-end=\"1248\" data-start=\"1222\"\u003eAdministration Routes:\u003c\/strong\u003e Typically administered via subcutaneous injection in experimental studies due to peptide stability and bioavailability considerations\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr class=\"\" data-end=\"1387\" data-start=\"1384\"\u003e\n\u003ch2 class=\"\" data-end=\"1411\" data-start=\"1389\"\u003eMechanism of Action\u003c\/h2\u003e\n\u003cp class=\"\" data-end=\"1493\" data-start=\"1413\"\u003eMOTS-c acts primarily through metabolic modulation and mitochondrial regulation:\u003c\/p\u003e\n\u003ch3 class=\"\" data-end=\"1546\" data-start=\"1495\"\u003e1. Metabolic Regulation and Insulin Sensitivity\u003c\/h3\u003e\n\u003cul data-end=\"1775\" data-start=\"1547\"\u003e\n\u003cli class=\"\" data-end=\"1697\" data-start=\"1547\"\u003e\n\u003cp class=\"\" data-end=\"1697\" data-start=\"1549\"\u003eActivates the AMPK (AMP-activated protein kinase) pathway, a critical regulator of energy homeostasis, glucose metabolism, and fatty acid oxidation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"1775\" data-start=\"1698\"\u003e\n\u003cp class=\"\" data-end=\"1775\" data-start=\"1700\"\u003eImproves insulin sensitivity, glucose uptake, and overall metabolic health.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"\" data-end=\"1836\" data-start=\"1777\"\u003e2. Enhancement of Mitochondrial Function and Biogenesis\u003c\/h3\u003e\n\u003cul data-end=\"2023\" data-start=\"1837\"\u003e\n\u003cli class=\"\" data-end=\"1927\" data-start=\"1837\"\u003e\n\u003cp class=\"\" data-end=\"1927\" data-start=\"1839\"\u003eIncreases mitochondrial biogenesis and efficiency, enhancing cellular energy production.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"2023\" data-start=\"1928\"\u003e\n\u003cp class=\"\" data-end=\"2023\" data-start=\"1930\"\u003eMay protect against metabolic disorders and aging-related declines in mitochondrial function.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"\" data-end=\"2076\" data-start=\"2025\"\u003e3. Anti-inflammatory and Cytoprotective Effects\u003c\/h3\u003e\n\u003cul data-end=\"2183\" data-start=\"2077\"\u003e\n\u003cli class=\"\" data-end=\"2183\" data-start=\"2077\"\u003e\n\u003cp class=\"\" data-end=\"2183\" data-start=\"2079\"\u003eReduces inflammation and oxidative stress, potentially protecting tissues from chronic metabolic stress.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"\" data-end=\"2231\" data-start=\"2185\"\u003e4. Exercise Mimetic (\"Exercise in a Pill\")\u003c\/h3\u003e\n\u003cul data-end=\"2378\" data-start=\"2232\"\u003e\n\u003cli class=\"\" data-end=\"2378\" data-start=\"2232\"\u003e\n\u003cp class=\"\" data-end=\"2378\" data-start=\"2234\"\u003eMOTS-c mimics some beneficial effects of exercise, potentially improving endurance, performance, and metabolic health without physical activity.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr class=\"\" data-end=\"2383\" data-start=\"2380\"\u003e\n\u003ch2 class=\"\" data-end=\"2439\" data-start=\"2385\"\u003ePotential Therapeutic and Experimental Applications\u003c\/h2\u003e\n\u003cp class=\"\" data-end=\"2527\" data-start=\"2441\"\u003eMOTS-c has shown promising potential in several preclinical and experimental contexts:\u003c\/p\u003e\n\u003ch3 class=\"\" data-end=\"2574\" data-start=\"2529\"\u003e1. Type 2 Diabetes and Insulin Resistance\u003c\/h3\u003e\n\u003cul data-end=\"2737\" data-start=\"2575\"\u003e\n\u003cli class=\"\" data-end=\"2737\" data-start=\"2575\"\u003e\n\u003cp class=\"\" data-end=\"2737\" data-start=\"2577\"\u003eDemonstrates significant improvements in glucose regulation and insulin sensitivity, potentially beneficial for managing type 2 diabetes and metabolic syndrome.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"\" data-end=\"2775\" data-start=\"2739\"\u003e2. Obesity and Weight Management\u003c\/h3\u003e\n\u003cul data-end=\"2901\" data-start=\"2776\"\u003e\n\u003cli class=\"\" data-end=\"2901\" data-start=\"2776\"\u003e\n\u003cp class=\"\" data-end=\"2901\" data-start=\"2778\"\u003eEnhances fatty acid oxidation, energy expenditure, and metabolism, potentially aiding in weight loss or obesity prevention.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"\" data-end=\"2937\" data-start=\"2903\"\u003e3. Longevity and Healthy Aging\u003c\/h3\u003e\n\u003cul data-end=\"3169\" data-start=\"2938\"\u003e\n\u003cli class=\"\" data-end=\"3068\" data-start=\"2938\"\u003e\n\u003cp class=\"\" data-end=\"3068\" data-start=\"2940\"\u003eProposed as a novel longevity-promoting compound due to mitochondrial protection, improved metabolism, and reduced inflammation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"3169\" data-start=\"3069\"\u003e\n\u003cp class=\"\" data-end=\"3169\" data-start=\"3071\"\u003eMay prevent age-related metabolic dysfunction, sarcopenia (muscle wasting), and cognitive decline.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"\" data-end=\"3199\" data-start=\"3171\"\u003e4. Cardiovascular Health\u003c\/h3\u003e\n\u003cul data-end=\"3327\" data-start=\"3200\"\u003e\n\u003cli class=\"\" data-end=\"3327\" data-start=\"3200\"\u003e\n\u003cp class=\"\" data-end=\"3327\" data-start=\"3202\"\u003ePotentially beneficial for cardiovascular disease prevention due to anti-inflammatory, metabolic, and antioxidant properties.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"\" data-end=\"3382\" data-start=\"3329\"\u003e5. Physical Performance and Endurance Enhancement\u003c\/h3\u003e\n\u003cul data-end=\"3552\" data-start=\"3383\"\u003e\n\u003cli class=\"\" data-end=\"3552\" data-start=\"3383\"\u003e\n\u003cp class=\"\" data-end=\"3552\" data-start=\"3385\"\u003ePreclinical studies suggest MOTS-c enhances physical endurance, exercise performance, and muscular efficiency, leading to interest as a performance-enhancing compound.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr class=\"\" data-end=\"3557\" data-start=\"3554\"\u003e\n\u003ch2 class=\"\" data-end=\"3610\" data-start=\"3559\"\u003eDosage and Administration (Experimental Context)\u003c\/h2\u003e\n\u003cp class=\"\" data-end=\"3774\" data-start=\"3612\"\u003eNo established clinical dosage guidelines exist due to limited human studies. Typical experimental dosages based on preclinical studies and anecdotal reports are:\u003c\/p\u003e\n\u003cul data-end=\"4064\" data-start=\"3776\"\u003e\n\u003cli class=\"\" data-end=\"3867\" data-start=\"3776\"\u003e\n\u003cp class=\"\" data-end=\"3867\" data-start=\"3778\"\u003e\u003cstrong data-end=\"3795\" data-start=\"3778\"\u003eDosage Range:\u003c\/strong\u003e 5–15 mg per administration (common experimental doses: 5–10 mg weekly).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"3945\" data-start=\"3868\"\u003e\n\u003cp class=\"\" data-end=\"3945\" data-start=\"3870\"\u003e\u003cstrong data-end=\"3898\" data-start=\"3870\"\u003eRoute of Administration:\u003c\/strong\u003e Subcutaneous injection, typically once weekly.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"4064\" data-start=\"3946\"\u003e\n\u003cp class=\"\" data-end=\"4064\" data-start=\"3948\"\u003e\u003cstrong data-end=\"3978\" data-start=\"3948\"\u003eExperimental Cycle Length:\u003c\/strong\u003e Usually administered experimentally over 4–8 weeks, followed by an evaluation period.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"\" data-end=\"4201\" data-start=\"4066\"\u003e\u003cstrong data-end=\"4075\" data-start=\"4066\"\u003eNote:\u003c\/strong\u003e The above dosages are experimental and not clinically validated; human equivalent dosages require rigorous clinical research.\u003c\/p\u003e\n\u003chr class=\"\" data-end=\"4206\" data-start=\"4203\"\u003e\n\u003ch2 class=\"\" data-end=\"4242\" data-start=\"4208\"\u003eSafety Profile and Side Effects\u003c\/h2\u003e\n\u003cp class=\"\" data-end=\"4387\" data-start=\"4244\"\u003eDue to the limited clinical human trials, full safety profiles remain preliminary; however, preclinical studies suggest favorable tolerability:\u003c\/p\u003e\n\u003ch3 class=\"\" data-end=\"4440\" data-start=\"4389\"\u003eCommon Side Effects (Rare and Mildly Reported):\u003c\/h3\u003e\n\u003cul data-end=\"4565\" data-start=\"4441\"\u003e\n\u003cli class=\"\" data-end=\"4496\" data-start=\"4441\"\u003e\n\u003cp class=\"\" data-end=\"4496\" data-start=\"4443\"\u003eMild injection-site discomfort, redness, or swelling.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"4565\" data-start=\"4497\"\u003e\n\u003cp class=\"\" data-end=\"4565\" data-start=\"4499\"\u003eTransient dizziness, mild fatigue, or headaches (rarely reported).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"\" data-end=\"4598\" data-start=\"4567\"\u003eLong-term Safety and Risks:\u003c\/h3\u003e\n\u003cul data-end=\"4739\" data-start=\"4599\"\u003e\n\u003cli class=\"\" data-end=\"4646\" data-start=\"4599\"\u003e\n\u003cp class=\"\" data-end=\"4646\" data-start=\"4601\"\u003eInsufficient long-term safety data available.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"4739\" data-start=\"4647\"\u003e\n\u003cp class=\"\" data-end=\"4739\" data-start=\"4649\"\u003eNo reported evidence of dependency, addiction, or withdrawal symptoms in existing studies.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr class=\"\" data-end=\"4744\" data-start=\"4741\"\u003e\n\u003ch2 class=\"\" data-end=\"4782\" data-start=\"4746\"\u003eContraindications and Precautions\u003c\/h2\u003e\n\u003cul data-end=\"5265\" data-start=\"4784\"\u003e\n\u003cli class=\"\" data-end=\"4921\" data-start=\"4784\"\u003e\n\u003cp class=\"\" data-end=\"4808\" data-start=\"4786\"\u003e\u003cstrong data-end=\"4808\" data-start=\"4786\"\u003eContraindications:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"4921\" data-start=\"4811\"\u003e\n\u003cli class=\"\" data-end=\"4866\" data-start=\"4811\"\u003e\n\u003cp class=\"\" data-end=\"4866\" data-start=\"4813\"\u003ePregnancy and breastfeeding (unknown safety profile).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"4921\" data-start=\"4869\"\u003e\n\u003cp class=\"\" data-end=\"4921\" data-start=\"4871\"\u003eKnown hypersensitivity to peptide-based compounds.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"5088\" data-start=\"4923\"\u003e\n\u003cp class=\"\" data-end=\"4947\" data-start=\"4925\"\u003e\u003cstrong data-end=\"4947\" data-start=\"4925\"\u003eDrug Interactions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"5088\" data-start=\"4950\"\u003e\n\u003cli class=\"\" data-end=\"5088\" data-start=\"4950\"\u003e\n\u003cp class=\"\" data-end=\"5088\" data-start=\"4952\"\u003eLimited known drug interactions; caution advised when used concurrently with insulin, oral hypoglycemics, or other metabolic modulators.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"5265\" data-start=\"5090\"\u003e\n\u003cp class=\"\" data-end=\"5108\" data-start=\"5092\"\u003e\u003cstrong data-end=\"5108\" data-start=\"5092\"\u003ePrecautions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"5265\" data-start=\"5111\"\u003e\n\u003cli class=\"\" data-end=\"5265\" data-start=\"5111\"\u003e\n\u003cp class=\"\" data-end=\"5265\" data-start=\"5113\"\u003ePatients with severe metabolic disorders or insulin-dependent diabetes should consult healthcare professionals due to MOTS-c’s potent metabolic effects.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr class=\"\" data-end=\"5270\" data-start=\"5267\"\u003e\n\u003ch2 class=\"\" data-end=\"5302\" data-start=\"5272\"\u003eLegal and Regulatory Status\u003c\/h2\u003e\n\u003cul data-end=\"5661\" data-start=\"5304\"\u003e\n\u003cli class=\"\" data-end=\"5449\" data-start=\"5304\"\u003e\n\u003cp class=\"\" data-end=\"5449\" data-start=\"5306\"\u003e\u003cstrong data-end=\"5334\" data-start=\"5306\"\u003eApproval and Regulation:\u003c\/strong\u003e MOTS-c is currently not approved by major regulatory agencies (FDA, EMA, Health Canada) for therapeutic human use.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"5560\" data-start=\"5450\"\u003e\n\u003cp class=\"\" data-end=\"5560\" data-start=\"5452\"\u003eTypically available as a \"research peptide\" or experimental compound labeled as \"not for human consumption.\"\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"5661\" data-start=\"5561\"\u003e\n\u003cp class=\"\" data-end=\"5661\" data-start=\"5563\"\u003eNot explicitly banned by WADA; athletes should confirm updated regulations before competitive use.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr class=\"\" data-end=\"5666\" data-start=\"5663\"\u003e\n\u003ch2 class=\"\" data-end=\"5707\" data-start=\"5668\"\u003eCurrent Research Status and Evidence\u003c\/h2\u003e\n\u003cul data-end=\"6429\" data-start=\"5709\"\u003e\n\u003cli class=\"\" data-end=\"5901\" data-start=\"5709\"\u003e\n\u003cp class=\"\" data-end=\"5736\" data-start=\"5711\"\u003e\u003cstrong data-end=\"5736\" data-start=\"5711\"\u003ePreclinical Research:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"5901\" data-start=\"5739\"\u003e\n\u003cli class=\"\" data-end=\"5901\" data-start=\"5739\"\u003e\n\u003cp class=\"\" data-end=\"5901\" data-start=\"5741\"\u003eNumerous animal studies demonstrate significant metabolic improvements, endurance enhancement, longevity-related effects, and mitochondrial protective benefits.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"6193\" data-start=\"5903\"\u003e\n\u003cp class=\"\" data-end=\"5931\" data-start=\"5905\"\u003e\u003cstrong data-end=\"5931\" data-start=\"5905\"\u003eHuman Clinical Trials:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"6193\" data-start=\"5934\"\u003e\n\u003cli class=\"\" data-end=\"6013\" data-start=\"5934\"\u003e\n\u003cp class=\"\" data-end=\"6013\" data-start=\"5936\"\u003eVery limited, with initial exploratory studies ongoing or in planning stages.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"6193\" data-start=\"6016\"\u003e\n\u003cp class=\"\" data-end=\"6193\" data-start=\"6018\"\u003ePreliminary small-scale observational studies and anecdotal evidence suggest metabolic benefits and improved exercise tolerance, though larger controlled trials are necessary.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"6429\" data-start=\"6195\"\u003e\n\u003cp class=\"\" data-end=\"6244\" data-start=\"6197\"\u003e\u003cstrong data-end=\"6244\" data-start=\"6197\"\u003eResearch Limitations and Future Directions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"6429\" data-start=\"6247\"\u003e\n\u003cli class=\"\" data-end=\"6327\" data-start=\"6247\"\u003e\n\u003cp class=\"\" data-end=\"6327\" data-start=\"6249\"\u003eLack of extensive human clinical data and randomized controlled trials (RCTs).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"6429\" data-start=\"6330\"\u003e\n\u003cp class=\"\" data-end=\"6429\" data-start=\"6332\"\u003eNeed for standardized dosing, long-term safety evaluation, and clearly defined clinical efficacy.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr class=\"\" data-end=\"6434\" data-start=\"6431\"\u003e\n\u003ch2 class=\"\" data-end=\"6478\" data-start=\"6436\"\u003eSummary of Potential Benefits and Risks\u003c\/h2\u003e\n\u003cdiv class=\"group pointer-events-none relative flex justify-center *:pointer-events-auto\"\u003e\n\u003cspan data-state=\"closed\" class=\"pointer-events-none absolute start-full top-4 z-10 hidden h-full w-fit ps-2 md:block\"\u003e\u003cbutton class=\"hover:bg-token-main-surface-secondary text-token-text-secondary pointer-events-auto rounded-lg px-1 py-1 opacity-0 transition-opacity duration-200 group-focus-within:opacity-100 group-hover:opacity-100\"\u003e\u003csvg class=\"icon-md-heavy\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" fill=\"none\" viewbox=\"0 0 24 24\" height=\"24\" width=\"24\"\u003e\u003cpath fill=\"currentColor\" d=\"M7 5C7 3.34315 8.34315 2 10 2H19C20.6569 2 22 3.34315 22 5V14C22 15.6569 20.6569 17 19 17H17V19C17 20.6569 15.6569 22 14 22H5C3.34315 22 2 20.6569 2 19V10C2 8.34315 3.34315 7 5 7H7V5ZM9 7H14C15.6569 7 17 8.34315 17 10V15H19C19.5523 15 20 14.5523 20 14V5C20 4.44772 19.5523 4 19 4H10C9.44772 4 9 4.44772 9 5V7ZM5 9C4.44772 9 4 9.44772 4 10V19C4 19.5523 4.44772 20 5 20H14C14.5523 20 15 19.5523 15 19V10C15 9.44772 14.5523 9 14 9H5Z\" clip-rule=\"evenodd\" fill-rule=\"evenodd\"\u003e\u003c\/path\u003e\u003c\/svg\u003e\u003c\/button\u003e\u003c\/span\u003e\n\u003cdiv class=\"tableContainer horzScrollShadows relative\"\u003e\n\u003ctable data-end=\"7150\" data-start=\"6480\" class=\"min-w-full\"\u003e\n\u003cthead data-end=\"6590\" data-start=\"6480\"\u003e\n\u003ctr data-end=\"6590\" data-start=\"6480\"\u003e\n\u003cth data-end=\"6537\" data-start=\"6480\"\u003e\u003cstrong data-end=\"6504\" data-start=\"6482\"\u003ePotential Benefits\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-end=\"6590\" data-start=\"6537\"\u003e\u003cstrong data-end=\"6574\" data-start=\"6539\"\u003ePotential Risks and Limitations\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"7150\" data-start=\"6703\"\u003e\n\u003ctr data-end=\"6814\" data-start=\"6703\"\u003e\n\u003ctd data-end=\"6760\" data-start=\"6703\" class=\"max-w-[calc(var(--thread-content-max-width)*2\/3)] min-w-[calc(var(--thread-content-max-width)\/3)]\"\u003eImproved insulin sensitivity and metabolic health\u003c\/td\u003e\n\u003ctd data-end=\"6814\" data-start=\"6760\" class=\"max-w-[calc(var(--thread-content-max-width)*2\/3)]\"\u003eLimited human clinical data\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6926\" data-start=\"6815\"\u003e\n\u003ctd data-end=\"6872\" data-start=\"6815\" class=\"max-w-[calc(var(--thread-content-max-width)*2\/3)] min-w-[calc(var(--thread-content-max-width)\/3)]\"\u003ePotential longevity and anti-aging effects\u003c\/td\u003e\n\u003ctd data-end=\"6926\" data-start=\"6872\" class=\"max-w-[calc(var(--thread-content-max-width)*2\/3)]\"\u003eUnclear long-term safety profile\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7038\" data-start=\"6927\"\u003e\n\u003ctd data-end=\"6984\" data-start=\"6927\" class=\"max-w-[calc(var(--thread-content-max-width)*2\/3)] min-w-[calc(var(--thread-content-max-width)\/3)]\"\u003eEnhanced exercise performance and endurance\u003c\/td\u003e\n\u003ctd data-end=\"7038\" data-start=\"6984\" class=\"max-w-[calc(var(--thread-content-max-width)*2\/3)] min-w-[calc(var(--thread-content-max-width)\/3)]\"\u003ePossible interactions with metabolic medications\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7150\" data-start=\"7039\"\u003e\n\u003ctd data-end=\"7096\" data-start=\"7039\" class=\"max-w-[calc(var(--thread-content-max-width)*2\/3)] min-w-[calc(var(--thread-content-max-width)\/3)]\"\u003eAnti-inflammatory and mitochondrial protective effects\u003c\/td\u003e\n\u003ctd data-end=\"7150\" data-start=\"7096\" class=\"max-w-[calc(var(--thread-content-max-width)*2\/3)] min-w-[calc(var(--thread-content-max-width)\/3)]\"\u003eRegulatory uncertainty; experimental availability\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr class=\"\" data-end=\"7155\" data-start=\"7152\"\u003e\n\u003ch2 class=\"\" data-end=\"7196\" data-start=\"7157\"\u003eFuture Directions and Research Needs\u003c\/h2\u003e\n\u003cul data-end=\"7569\" data-start=\"7198\"\u003e\n\u003cli class=\"\" data-end=\"7312\" data-start=\"7198\"\u003e\n\u003cp class=\"\" data-end=\"7312\" data-start=\"7200\"\u003eConduct rigorous human clinical trials to establish efficacy, safety, optimal dosing, and therapeutic potential.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"7428\" data-start=\"7313\"\u003e\n\u003cp class=\"\" data-end=\"7428\" data-start=\"7315\"\u003eLong-term studies needed to evaluate potential chronic effects, safety, and effectiveness in various populations.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"7569\" data-start=\"7429\"\u003e\n\u003cp class=\"\" data-end=\"7569\" data-start=\"7431\"\u003eExploration of MOTS-c’s therapeutic potential in metabolic diseases, aging, cardiovascular diseases, and physical performance enhancement.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr class=\"\" data-end=\"7574\" data-start=\"7571\"\u003e\n\u003ch2 class=\"\" data-end=\"7589\" data-start=\"7576\"\u003eConclusion\u003c\/h2\u003e\n\u003cp class=\"\" data-end=\"8132\" data-start=\"7591\"\u003eMOTS-c is a promising mitochondrial-derived peptide with demonstrated metabolic, mitochondrial, and potential anti-aging benefits. Preclinical research strongly supports its potential role in managing metabolic disorders, promoting healthy aging, and enhancing exercise performance. However, significant gaps in clinical research, dosing standardization, and long-term safety evaluations remain. Until comprehensive human studies confirm safety and efficacy, MOTS-c remains a novel experimental compound with substantial therapeutic promise.\u003c\/p\u003e\n\u003chr class=\"\" data-end=\"8137\" data-start=\"8134\"\u003e\n\u003ch2 class=\"\" data-end=\"8172\" data-start=\"8139\"\u003eReferences \u003c\/h2\u003e\n\u003cul data-end=\"8817\" data-start=\"8174\"\u003e\n\u003cli class=\"\" data-end=\"8352\" data-start=\"8174\"\u003e\n\u003cp class=\"\" data-end=\"8352\" data-start=\"8176\"\u003eLee, C., et al. (2015). \"The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.\" \u003cem data-end=\"8335\" data-start=\"8318\"\u003eCell Metabolism\u003c\/em\u003e, 21(3), 443–454.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"8510\" data-start=\"8353\"\u003e\n\u003cp class=\"\" data-end=\"8510\" data-start=\"8355\"\u003eKim, K. H., \u0026amp; Son, J. M. (2019). \"Mitochondrial peptides as promising targets for age-related metabolic disorders.\" \u003cem data-end=\"8497\" data-start=\"8471\"\u003eExperimental Gerontology\u003c\/em\u003e, 121, 15–19.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"\" data-end=\"8703\" data-start=\"8511\"\u003e\n\u003cp class=\"\" data-end=\"8703\" data-start=\"8513\"\u003eReynolds, J. C., et al. (2021). \"MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis.\" \u003cem data-end=\"8690\" data-start=\"8667\"\u003eNature Communications\u003c\/em\u003e, 12(1), 470.\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"\" data-end=\"9145\" data-start=\"8824\"\u003e\u003cstrong data-end=\"8839\" data-start=\"8824\"\u003eDisclaimer:\u003c\/strong\u003e\u003cbr data-end=\"8842\" data-start=\"8839\"\u003eThis product  is provided exclusively for educational purposes. MOTS-c is an experimental research compound and has not been approved by major health regulatory authorities for clinical therapeutic use. Always consult qualified healthcare providers before considering experimental peptides or supplements.\u003c\/p\u003e","brand":"Mijn winkel","offers":[{"title":"Default Title","offer_id":55161618596104,"sku":null,"price":70.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0937\/9053\/5944\/files\/Mots-c_40mg.png?v=1774735836","url":"https:\/\/rcpeptides.com\/zh\/products\/mots-c-40mg-vial","provider":"RCpeptides","version":"1.0","type":"link"}